We again performed an ELISA, but now using plasma fractions from healthy donors (n = 10) and fractions from patients with cervical cancer (n = 20) to determine the levels of CMTM6 per fraction (Figure 2). The gene discussed is CMTM6; the disease is cervical cancer.